Correlation Between Mydecine Innovations and Moolec Science

Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Moolec Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Moolec Science into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mydecine Innovations Group and Moolec Science SA, you can compare the effects of market volatilities on Mydecine Innovations and Moolec Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Moolec Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Moolec Science.

Diversification Opportunities for Mydecine Innovations and Moolec Science

0.05

Correlation Coefficient

Mydecine Innovations  Moolec Science

Significant diversification

The 3 months correlation between Mydecine and Moolec is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Moolec Science SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moolec Science SA and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Moolec Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moolec Science SA has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Moolec Science go up and down completely randomly.

Pair Corralation between Mydecine Innovations and Moolec Science

Assuming the 90 days horizon Mydecine Innovations Group is expected to generate 8.16 times more return on investment than Moolec Science. However, Mydecine Innovations is 8.16 times more volatile than Moolec Science SA. It trades about 0.2 of its potential returns per unit of risk. Moolec Science SA is currently generating about -0.18 per unit of risk. If you would invest  0.30  in Mydecine Innovations Group on May 1, 2025 and sell it today you would earn a total of  0.04  from holding Mydecine Innovations Group or generate 13.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mydecine Innovations Group  vs.  Moolec Science SA

Mydecine Innovations

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Moolec Science SA

Risk-Adjusted Performance

Very Weak

Over the last 90 days Moolec Science SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in August 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Mydecine Innovations and Moolec Science

The main advantage of trading using opposite Mydecine Innovations and Moolec Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Moolec Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moolec Science will offset losses from the drop in Moolec Science's long position.

The idea behind Mydecine Innovations Group and Moolec Science SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.